Purpose: Sporadic Alzheimer’s disease (AD) accounts for over 95% of cases. Possible mechanisms of AD such as inflammation and oxidative stresses in the brain motivate researchers to follow many therapies which would be effective, especially in the early stages of the disease. IMOD, the herbal extract of R. Canina, T. Vulgare and U. Dioica plant species enriched with selenium, has anti-inflammatory, immunoregulatory and protective effects against oxidative stress. Methods: In this study three AD-related genes, DAXX, NFκβ and VEGF, were chosen as candidate to investigate the neuroprotective effect of the extract by comparing their expression levels in the hippocampus of rat model of sporadic AD, using qPCR in the herbal-treated and control g...
Some animal models have been used to study Alzheimer᾽s disease (AD). AD is an irreversible progressi...
The present study was designed to evaluate the anti oxidant and neuroprotective effect of ethanolic ...
Alzheimer’s disease (AD) is the most common form of dementia, currently affecting 50 million people ...
63-73Alzheimer’s disease (AD) is a well known progressive neurodegenerative disorder having complex ...
Alzheimer's disease is a progressive neurodegenerative disease manifesting in cognitive decline, imp...
Alzheimer's disease (AD) is a progressive brain disorder that gradually impairs the person's memory ...
Alzheimer’s disease (AD) is a prevalent neurodegenerative disorder. With the aging population and th...
Alzheimer's disease is the most common cause of dementia, accounting for an estimated 60% to 80% of ...
© 2020 John Wiley & Sons, Ltd. Alzheimer's disease (AD) is clinically characterized as memory defi...
In this study, we have reported the herbal formula B401 that has neuroprotective effects via multifu...
Alzheimer’s disease (AD) is a chronic, progressive, neurodegenerative disorder that places a substan...
Alzheimer’s disease (AD) is a neurodegenerative disorder manifested by decline in memory and mild co...
Feixue Wang,1 Jianchao Feng,2 Yang Yang,1 Jiangang Liu,3 Meixia Liu,1 Zhiyong Wang,1 Hui Pei,1 Yun W...
Background and objectives: Alzheimer's disease (AD) as a neurodegenerative disorder is the most comm...
Alzheimer’s disease (AD) is a devastating and debilitating neurological brain disorder that has a mu...
Some animal models have been used to study Alzheimer᾽s disease (AD). AD is an irreversible progressi...
The present study was designed to evaluate the anti oxidant and neuroprotective effect of ethanolic ...
Alzheimer’s disease (AD) is the most common form of dementia, currently affecting 50 million people ...
63-73Alzheimer’s disease (AD) is a well known progressive neurodegenerative disorder having complex ...
Alzheimer's disease is a progressive neurodegenerative disease manifesting in cognitive decline, imp...
Alzheimer's disease (AD) is a progressive brain disorder that gradually impairs the person's memory ...
Alzheimer’s disease (AD) is a prevalent neurodegenerative disorder. With the aging population and th...
Alzheimer's disease is the most common cause of dementia, accounting for an estimated 60% to 80% of ...
© 2020 John Wiley & Sons, Ltd. Alzheimer's disease (AD) is clinically characterized as memory defi...
In this study, we have reported the herbal formula B401 that has neuroprotective effects via multifu...
Alzheimer’s disease (AD) is a chronic, progressive, neurodegenerative disorder that places a substan...
Alzheimer’s disease (AD) is a neurodegenerative disorder manifested by decline in memory and mild co...
Feixue Wang,1 Jianchao Feng,2 Yang Yang,1 Jiangang Liu,3 Meixia Liu,1 Zhiyong Wang,1 Hui Pei,1 Yun W...
Background and objectives: Alzheimer's disease (AD) as a neurodegenerative disorder is the most comm...
Alzheimer’s disease (AD) is a devastating and debilitating neurological brain disorder that has a mu...
Some animal models have been used to study Alzheimer᾽s disease (AD). AD is an irreversible progressi...
The present study was designed to evaluate the anti oxidant and neuroprotective effect of ethanolic ...
Alzheimer’s disease (AD) is the most common form of dementia, currently affecting 50 million people ...